As of Jul 20
| +0.12 / +1.68%|
The 2 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 4.25, with a high estimate of 6.50 and a low estimate of 2.00. The median estimate represents a -41.38% decrease from the last price of 7.25.
The current consensus among 2 polled investment analysts is to Hold stock in Rockwell Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.